Indication
Megace ES (megestrol acetate) is a concentrated suspension indicated for the treatment of anorexia (loss of appetite),
cachexia (severe malnutrition), or an unexplained, significant weight loss in people with a diagnosis of AIDS.1
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch, or
call 1-800-FDA-1088.
Megace ES is available by Prescription Only. For full Prescribing Information, click here.
© 2009 PAR Pharmaceutical, Inc. All rights reserved. Par licensed the Megace® name from Bristol-Myers Squibb Company.